T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Apple
AAPL
|
+$4.53B |
| 2 |
Broadcom
AVGO
|
+$1.7B |
| 3 |
GE Vernova
GEV
|
+$1.29B |
| 4 |
International Paper
IP
|
+$1.11B |
| 5 |
Tesla
TSLA
|
+$956M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$2.44B |
| 2 |
NVIDIA
NVDA
|
+$2.09B |
| 3 |
Constellation Energy
CEG
|
+$1.9B |
| 4 |
Qualcomm
QCOM
|
+$1.84B |
| 5 |
Amazon
AMZN
|
+$1.56B |
Sector Composition
| 1 | Technology | 34% |
| 2 | Healthcare | 14.89% |
| 3 | Financials | 10.35% |
| 4 | Consumer Discretionary | 10.1% |
| 5 | Communication Services | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
851
Rollins
ROL
$27.2B
| $30.1M | ﹤0.01% |
616,348
+13,488
| +2% | +$658K |
|
|
BCPC
852
Balchem Corporation
BCPC
$4.95B
| $30.1M | ﹤0.01% |
195,335
+2,189
| +1% | +$337K |
|
853
Grupo Aeroportuario del Sureste
ASR
$10.1B
| $29.9M | ﹤0.01% |
99,946
-2,829
| -3% | -$847K |
|
854
Sterling Infrastructure
STRL
$9.76B
| $29.7M | ﹤0.01% |
250,904
+221,448
| +752% | +$26.2M |
|
855
Payoneer
PAYO
$2.44B
| $29.5M | ﹤0.01% |
5,326,317
+535,917
| +11% | +$2.97M |
|
856
Sapiens International
SPNS
$2.4B
| $29.3M | ﹤0.01% |
864,742
+9,205
| +1% | +$312K |
|
857
Enphase Energy
ENPH
$5.06B
| $29.3M | ﹤0.01% |
294,097
-112,270
| -28% | -$11.2M |
|
858
Workiva
WK
$4.56B
| $28.9M | ﹤0.01% |
395,301
+4,362
| +1% | +$318K |
|
859
First Industrial Realty Trust
FR
$6.85B
| $28.8M | ﹤0.01% |
606,434
-18,204
| -3% | -$865K |
|
860
Haemonetics
HAE
$2.41B
| $28.8M | ﹤0.01% |
348,061
-214,393
| -38% | -$17.7M |
|
861
Zai Lab
ZLAB
$3.63B
| $28.7M | ﹤0.01% |
1,657,915
+7,128
| +0.4% | +$124K |
|
862
Simply Good Foods
SMPL
$2.67B
| $28.5M | ﹤0.01% |
788,286
+680
| +0.1% | +$24.6K |
|
|
BOW
863
Bowhead Specialty Holdings
BOW
$979M
| $28.4M | ﹤0.01% |
+1,122,573
| New | +$28.4M |
|
864
Invitation Homes
INVH
$18.2B
| $28.4M | ﹤0.01% |
791,080
+19,707
| +3% | +$707K |
|
865
UFP Technologies
UFPT
$1.58B
| $28.2M | ﹤0.01% |
106,834
+63,700
| +148% | +$16.8M |
|
|
IGMS
866
DELISTED
IGM Biosciences
IGMS
| $28M | ﹤0.01% |
4,075,091
+187,068
| +5% | +$1.29M |
|
867
Iovance Biotherapeutics
IOVA
$803M
| $27.9M | ﹤0.01% |
3,482,402
-1,785,462
| -34% | -$14.3M |
|
868
Northern Trust
NTRS
$24.7B
| $27.9M | ﹤0.01% |
332,465
+254
| +0.1% | +$21.3K |
|
869
Intellia Therapeutics
NTLA
$1.33B
| $27.9M | ﹤0.01% |
1,244,959
-380,092
| -23% | -$8.51M |
|
870
Camtek
CAMT
$4.07B
| $27.7M | ﹤0.01% |
+221,393
| New | +$27.7M |
|
871
Synchrony
SYF
$27.8B
| $27.6M | ﹤0.01% |
585,059
-715,517
| -55% | -$33.8M |
|
872
Eversource Energy
ES
$23.5B
| $27.6M | ﹤0.01% |
486,318
+20,064
| +4% | +$1.14M |
|
|
CNR
873
Core Natural Resources, Inc.
CNR
$3.97B
| $27.4M | ﹤0.01% |
268,614
+250,270
| +1,364% | +$25.5M |
|
874
Genuine Parts
GPC
$19.4B
| $27.4M | ﹤0.01% |
197,962
+5,035
| +3% | +$696K |
|
875
Valvoline
VVV
$5.15B
| $27.3M | ﹤0.01% |
630,801
+76,485
| +14% | +$3.3M |
|